Docetaxel, 5FU, oxaliplatin (TEFOX) in 1st line treatment of signet ring cell and/or poorly differentiated gastric adenocarcinoma: a retrospective study of AGEO

Affiliation auteurs!!!! Error affiliation !!!!
TitreDocetaxel, 5FU, oxaliplatin (TEFOX) in 1st line treatment of signet ring cell and/or poorly differentiated gastric adenocarcinoma: a retrospective study of AGEO
Type de publicationJournal Article
Year of Publication2015
AuteursPernot S, Dubreuil O, Tougeron D, Soudan D, Bachet JBaptiste, Lepere C, Le Malicot K, Taieb J, Rougier P
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume33
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/jco.2015.33.15_suppl.e15048